Emmanuelle Girard-Valenciennes
University of La Réunion
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Emmanuelle Girard-Valenciennes.
Fitoterapia | 2014
Nina Corlay; Leen Delang; Emmanuelle Girard-Valenciennes; Johan Neyts; Patricia Clerc; Jacqueline Smadja; Françoise Guéritte; Pieter Leyssen; Marc Litaudon
A bioassay-guided purification of an EtOAc extract of the leaves of Croton mauritianus using a chikungunya virus-cell-based assay led to the isolation of 12-O-decanoylphorbol-13-acetate (1) and the new 12-O-decanoyl-7-hydroperoxy-phorbol-5-ene-13-acetate (2), along with loliolide, vomifoliol, dehydrovomifoliol, annuionone D and bluemol C. The planar structure and the relative configuration of compound 2 were elucidated based on spectroscopic analysis, including 1D- and 2D-NMR experiments, mass spectrometry, and comparison with literature data. Compounds 1 and 2 inhibited chikungunya virus-induced cell death in cell culture with EC50s of 2.4±0.3 and 4.0±0.8 μM, respectively.
Marine Drugs | 2016
Mireille Fouillaud; Mekala Venkatachalam; Emmanuelle Girard-Valenciennes; Yanis Caro; Laurent Dufossé
Anthraquinones and their derivatives constitute a large group of quinoid compounds with about 700 molecules described. They are widespread in fungi and their chemical diversity and biological activities recently attracted attention of industries in such fields as pharmaceuticals, clothes dyeing, and food colorants. Their positive and/or negative effect(s) due to the 9,10-anthracenedione structure and its substituents are still not clearly understood and their potential roles or effects on human health are today strongly discussed among scientists. As marine microorganisms recently appeared as producers of an astonishing variety of structurally unique secondary metabolites, they may represent a promising resource for identifying new candidates for therapeutic drugs or daily additives. Within this review, we investigate the present knowledge about the anthraquinones and derivatives listed to date from marine-derived filamentous fungi′s productions. This overview highlights the molecules which have been identified in microorganisms for the first time. The structures and colors of the anthraquinoid compounds come along with the known roles of some molecules in the life of the organisms. Some specific biological activities are also described. This may help to open doors towards innovative natural substances.
Journal of Natural Products | 2015
Florent Olivon; Héliciane Palenzuela; Emmanuelle Girard-Valenciennes; Johan Neyts; Christophe Pannecouque; Fanny Roussi; Isabelle Grondin; Pieter Leyssen; Marc Litaudon
In an effort to identify new potent and selective inhibitors of chikungunya virus and HIV-1 and HIV-2 virus replication, the endemic Mascarene species Stillingia lineata was investigated. LC/MS and bioassay-guided purification of the EtOAc leaf extract using a chikungunya virus-cell-based assay led to the isolation of six new (4-9) and three known (1-3) tonantzitlolones possessing the rare C20-flexibilane skeleton, along with tonantzitloic acid (10), a new linear diterpenoid, and three new (11, 13, and 15) and two known (12 and 14) tigliane-type diterpenoids. The planar structures of the new compounds and their relative configurations were determined by spectroscopic analysis, and their absolute configurations were determined through comparison with literature data and from biogenetic considerations. These compounds were investigated for selective antiviral activity against chikungunya virus (CHIKV), Semliki Forest virus, Sindbis virus, and, for compounds 11-15, the HIV-1 and HIV-2 viruses. Compounds 12-15 were found to be the most potent and are selective inhibitors of CHIKV, HIV-1, and HIV-2 replication. In particular, compound 14 inhibited CHIKV replication with an EC50 value of 1.2 μM on CHIKV and a selectivity index of >240, while compound 15 inhibited HIV-1 and HIV-2 with EC50 values of 0.043 and 0.018 μM, respectively. It was demonstrated further that potency and selectivity are sensitive to the substitution pattern on the tigliane skeleton. The cytotoxic activities of compounds 1-10 were evaluated against the HCT-116, MCF-7, and PC3 cancer cell lines.
Fitoterapia | 2018
Cécile Apel; Jérôme Bignon; Maria Concepcion Garcia-Alvarez; Sarah Ciccone; Patricia Clerc; Isabelle Grondin; Emmanuelle Girard-Valenciennes; Jacqueline Smadja; Philippe Lopes; Michel Frederich; Fanny Roussi; Thierry Meinnel; Carmela Giglione; Marc Litaudon
N-myristoylation (Myr) is an eukaryotic N-terminal co- or post-translational protein modification in which the enzyme N-myristoyltransferase (NMT) transfers a fatty acid (C14:0) to the N-terminal glycine residues of several cellular key proteins. Depending on the cellular context, NMT may serve as a molecular target in anticancer or anti-infectious therapy, and drugs that inhibit this enzyme may be useful in the treatment of cancer or infectious diseases. As part of an on-going project to identify natural Homo sapiens N-myristoyltransferase 1 inhibitors (HsNMT1), two ellagitannins, punicalagin (1) and isoterchebulin (2), along with eschweilenol C (3) and ellagic acid (4) were isolated from the bark of Terminalia bentzoë (L.) L. f. subsp. bentzoë. Their structures were determined by means of spectroscopic analyses and comparison with literature data. Punicalagin (1) and isoterchebulin (2) showed significant inhibitory activity towards HsNMT1, and also against Plasmodium falciparum NMT (PfNMT) both in vitro and in cellulo, opening alternative paths for new NMT inhibitors development. This is the first report identifying natural products from a botanical source as inhibitors of HsNMT and PfNMT.
Journal of Ethnopharmacology | 2004
C. Poullain; Emmanuelle Girard-Valenciennes; Jacqueline Smadja
International Dairy Journal | 2016
Daniele Giuffrida; Nuthathai Sutthiwong; Paola Dugo; Paola Donato; Francesco Cacciola; Emmanuelle Girard-Valenciennes; Yves Le Mao; Christophe Monnet; Mireille Fouillaud; Yanis Caro; Laurent Dufossé
Phytochemistry Letters | 2015
S Techer; Emmanuelle Girard-Valenciennes; Pascal Retailleau; Johan Neyts; Françoise Guéritte; Pieter Leyssen; Marc Litaudon; Jacqueline Smadja; Isabelle Grondin
Journal of Food Composition and Analysis | 2018
Mekala Venkatachalam; Miroslava Zelená; Francesco Cacciola; Lenka Česlová; Emmanuelle Girard-Valenciennes; Patricia Clerc; Paola Dugo; Luigi Mondello; Mireille Fouillaud; Archimede Rotondo; Daniele Giuffrida; Laurent Dufossé
International Journal of Antimicrobial Agents | 2018
Allison Ledoux; Martine Cao; Olivia Jansen; Lucia Mamede; Pierre-Eric Campos; Bertrand Payet; Patricia Clerc; Isabelle Grondin; Emmanuelle Girard-Valenciennes; Thomas Hermann; Marc Litaudon; Charlotte Vanderheydt; Leen Delang; Johan Neyts; Pieter Leyssen; Michel Frederich; Jacqueline Smadja
Planta Medica | 2016
Florent Olivon; S Remy; Cécile Apel; S Técher-Giraud; Emmanuelle Girard-Valenciennes; Isabelle Grondin; Fanny Roussi; O Thoison; David Touboul; Marc Litaudon